{"id":"https://openalex.org/W1978005665","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.197","title":"Extended-Release Memantine (28 mg, Once Daily) and Sustained Behavioral Improvement: Post Hoc Responder Analysis from a Randomized Trial in Patients with Moderate to Severe Alzheimer's Disease (P04.197)","display_name":"Extended-Release Memantine (28 mg, Once Daily) and Sustained Behavioral Improvement: Post Hoc Responder Analysis from a Randomized Trial in Patients with Moderate to Severe Alzheimer's Disease (P04.197)","alternate_titles":[],"publication_year":2012,"publication_date":"2012-04-22","ids":{"openalex":"https://openalex.org/W1978005665","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.197","mag":"1978005665"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.78.1_meetingabstracts.p04.197","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.197","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.197","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978005665"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060487287","display_name":"Jeffrey L. Cummings","orcid":"https://orcid.org/0000-0001-8944-4158","observed_orcids":["https://orcid.org/0000-0001-8944-4158"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I2800445466","display_name":"Lou Ruvo Brain Institute","ror":"https://ror.org/03wqknk68","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800445466"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Cummings","raw_affiliation_strings":["Cleveland Clinic Lou Ruvo Center for Brain Health (Las Vegas, NV)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Lou Ruvo Center for Brain Health (Las Vegas, NV)","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I2800445466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009988073","display_name":"Suzanne B. Hendrix","orcid":"https://orcid.org/0000-0002-2374-7727","observed_orcids":["https://orcid.org/0000-0002-2374-7727"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Hendrix","raw_affiliation_strings":["Pentara Corporation Salt Lake City UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pentara Corporation Salt Lake City UT","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Miller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Miller","raw_affiliation_strings":["Prescott Medical Communications Group Chicago IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prescott Medical Communications Group Chicago IL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036745592","display_name":"Vojislav Pejovi\u0107","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. Pejovic","raw_affiliation_strings":["Prescott Medical Communications Group Chicago IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prescott Medical Communications Group Chicago IL","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Graham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4391012632","display_name":"Forest Laboratories (United States)","ror":"https://ror.org/01p3wva84","country_code":"US","type":"company","lineage":["https://openalex.org/I4391012632"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Graham","raw_affiliation_strings":["Forest Research Institute, Jersey City, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forest Research Institute, Jersey City, NJ","institution_ids":["https://openalex.org/I4391012632"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006081848","display_name":"Michael Tocco","orcid":"https://orcid.org/0000-0003-1474-6666","observed_orcids":["https://orcid.org/0000-0003-1474-6666"]},"institutions":[{"id":"https://openalex.org/I4391012632","display_name":"Forest Laboratories (United States)","ror":"https://ror.org/01p3wva84","country_code":"US","type":"company","lineage":["https://openalex.org/I4391012632"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Tocco","raw_affiliation_strings":["Forest Research Institute, Jersey City, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forest Research Institute, Jersey City, NJ","institution_ids":["https://openalex.org/I4391012632"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"Meeting Abstracts 1","first_page":"P04.197","last_page":"P04.197"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.8794000148773193,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.8794000148773193,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.10970000177621841,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.996999979019165},{"id":"https://openalex.org/keywords/behavioral-symptoms","display_name":"behavioral symptoms","score":0.6309999823570251},{"id":"https://openalex.org/keywords/neuropsychiatric-inventory","display_name":"Neuropsychiatric Inventory","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.7919999957084656}],"concepts":[{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.929178774356842},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.8118504285812378},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6190463304519653},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5718725919723511},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.5557147264480591},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4867801368236542},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.43193960189819336},{"id":"https://openalex.org/C99508421","wikidata":"https://www.wikidata.org/wiki/Q2678675","display_name":"Physical medicine and rehabilitation","level":1,"score":0.3942137360572815},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3435995876789093},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3326433300971985},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.33086466789245605},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.18013116717338562}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.78.1_meetingabstracts.p04.197","doi":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.197","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.78.1_meetingabstracts.p04.197","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2310992267","https://openalex.org/W2154945520","https://openalex.org/W2119851050","https://openalex.org/W2787707495","https://openalex.org/W2114206584","https://openalex.org/W2807914868","https://openalex.org/W2020466444","https://openalex.org/W2048388096","https://openalex.org/W2333098158","https://openalex.org/W1586998168"],"abstract_inverted_index":{"Objective:":[0],"To":[2],"assess":[3],"the":[4,40,75,157,245],"efficacy":[5],"of":[6,30,96,113,119,145,177,231,234,241,285,299],"extended-release":[7],"(ER)":[8],"memantine":[9,31,181,235,264,282],"on":[10,43,70],"sustained":[11,300],"behavioral":[12,301],"improvements":[13],"in":[14,39,51,121,412,425,441],"patients":[15,52,65,69,84,120,179,237,243,286],"with":[16,53,85,221,287,294,304,324,452,468,484,499],"moderate":[17,54,288],"to":[18,55,289],"severe":[19,56,290],"Alzheimer9s":[20],"disease":[21],"(AD).":[22],"Background":[25],"An":[27,256],"ER":[28,265,283],"formulation":[29],"(28":[32],"mg,":[33],"once":[34],"daily)":[35],"was":[36,102,207,292,429],"recently":[37],"approved":[38],"US":[41],"based":[42],"a":[44,60,105,202,229,295],"24-week,":[45],"randomized,":[46],"placebo-controlled":[47],"trial":[48],"(MEM-MD-50;":[49],"NCT00322153)":[50],"AD":[57,291],"concurrently":[58],"taking":[59],"cholinesterase":[61],"inhibitor.":[62],"Memantine":[63],"ER-treated":[64,236],"significantly":[66,296],"outperformed":[67],"placebo-treated":[68,216,242],"several":[71],"outcome":[72],"measures,":[73],"including":[74],"Neuropsychiatric":[76,403],"Inventory":[77],"(NPI),":[78],"an":[79,99,109,432,474,489,503],"instrument":[80],"for":[81,165,322,450,466,482,497],"assessing":[82],"behavior":[83],"dementia.":[86],"Design/Methods:":[89],"In":[91,277],"this":[92,126,278],"post":[93,279],"hoc":[94,280],"analysis":[95,258],"that":[97],"trial,":[98],"NPI":[100,188,223],"responder":[101],"defined":[103],"as":[104,431,473,488,502],"patient":[106],"who":[107,124],"demonstrated":[108],"improvement":[110,206],"over":[111],"baseline":[112],"at":[114,130,136,190,225],"least":[115],"3":[116,192,227],"points.":[117],"Percentages":[118],"each":[122],"group":[123],"achieved":[125],"response":[127,246],"(or":[128],"greater)":[129],"Week":[131,200],"12":[132],"and":[133,139,156,197,213,238,251,387,419,457],"maintained":[134,244],"it":[135],"Weeks":[137,248],"18":[138,250],"24":[140,252],"were":[141,150,168],"compared":[142,303],"by":[143,209],"means":[144],"Fisher9s":[146],"exact":[147],"test.":[148],"Data":[149],"analyzed":[151],"using":[152],"observed":[153],"cases":[154],"(OC)":[155],"last":[158],"observation":[159],"carried":[160],"forward":[161],"(LOCF)":[162],"approach;":[163],"corrections":[164],"multiple":[166],"comparisons":[167],"not":[169],"performed.":[170],"Results:":[173],"A":[175],"total":[176,230],"531":[178],"(261":[180],"ER,":[182],"270":[183],"placebo;":[184,269],"OC)":[185],"had":[186],"available":[187,222],"data":[189,224],"all":[191,226],"visits":[193],"(Weeks":[194],"12,":[195,201,249],"18,":[196],"24).":[198],"At":[199],"3-point":[203],"or":[204,395,398],"greater":[205],"experienced":[208],"131":[210],"(50.2%)":[211],"memantine-treated":[212],"127":[214],"(47.0%)":[215],"patients,":[217],"respectively.":[218],"Of":[219],"participants":[220],"visits,":[228],"39.5%":[232],"(103/261)":[233],"28.9%":[239],"(78/270)":[240],"across":[247],"(":[253],"P":[254,271],"=0.011).":[255],"LOCF":[257],"yielded":[259],"similar":[260],"results":[261],"(37.4%":[262],"[119/318]":[263],"vs.":[266],"27.4%":[267],"[88/321]":[268],"=0.007).":[272],"Conclusions:":[275],"analysis,":[281],"treatment":[284],"associated":[293],"higher":[297],"rate":[298],"improvement,":[302],"placebo.":[305],"Supported":[307],"by:":[308],"Forest":[309,344,458,485,500],"Laboratories,":[310,326,345,486],"Inc.":[311],"Disclosure:":[314],"Dr.":[316,390,405,427,434,444,460,476,491],"Cummings":[317,391,406,428],"has":[318,392,446,462,478,493],"received":[319,393,447,463,479,494],"personal":[320,448,464,480,495],"compensation":[321,449,465,481,496],"activities":[323,451,467,483,498],"Abbott":[325],"Inc.,":[327,340,346,348,350,363,367],"Acadia,":[328],"Acerra,":[329],"ADAMAS,":[330,413],"Anavex,":[331],"Astellas,":[332],"Avanir":[333],"Pharmaceuticals,":[334,379],"Baxter,":[335],"Bristol-Myers":[336],"Squibb":[337],"Company,":[338,356],"Eisai":[339],"Elan":[341],"Corporation,":[342],"EnVivo,":[343],"Genentech,":[347],"GlaxoSmithKline,":[349],"Janssen":[351],"Pharmaceutica,":[352],"Eli":[353],"Lilly":[354],"&":[355,365],"Lundbeck":[357],"Research":[358],"USA,":[359],"Inc,":[360,371],"Medivation,":[361],"Medtronic,":[362],"Merck":[364],"Co.,":[366],"Neurokos,":[368,418],"Novartis,":[369],"Pfizer":[370],"Prana,":[372,414],"QR,":[373],"Sonexa,":[374,415],"Takeda":[375],"Pharmaceutical,":[376],"Toyama,":[377],"Bayer":[378],"Avid,":[380],"GE":[381],"Healthcare,":[382],"MedAvante,":[383,416],"Neurotrax,":[384,417],"UCB":[385],"Pharma,":[386],"QR":[388,420],"Pharma.":[389],"(royalty":[394],"license":[396],"fee":[397],"contractual":[399],"rights)":[400],"payments":[401],"from":[402],"Inventory.":[404],"holds":[407,436],"stock":[408,410,437,439],"and/or":[409,438],"options":[411,440],"pharma,":[421],"which":[422,426],"sponsored":[423],"research":[424],"involved":[430],"investigator.":[433],"Hendrix":[435],"Pentara":[442],"Corporation.":[443],"Miller":[445],"Prescott":[453,469],"Medical":[454,470],"Communications":[455,471],"Group":[456,472],"Laboratories.":[459],"Pejovic":[461],"employee.":[475,490,504],"Graham":[477],"Inc":[487],"Tocco":[492],"Laboratories":[501]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1978005665","counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
